China's Humanoid Robots Face New Financial Hurdles

China’s rapid expansion in humanoid robotics is entering a critical phase of scrutiny. While government support and private capital have fueled a manufacturing boom, regulators are now signaling stricter requirements for companies aiming to go public. This shift marks a transition from celebrating technical milestones to demanding proof of commercial viability.

The immediate trigger appears to be the volatile market debut of Unitree Robotics. After surging fivefold on its first day of trading in Shanghai, the stock fell significantly, losing about half its peak value. This volatility has prompted regulators to emphasize the need for strong financials, credible revenue prospects, and meaningful technological innovation before approving new listings.

Regulators Demand Proof of Revenue

According to reports from The Wall Street Journal and Reuters, Chinese authorities have informally raised the bar for public offerings. Companies must now demonstrate recurring revenue and progress toward reducing losses. This regulatory stance reflects a broader concern that high valuations in the private market may not be supported by actual business performance.

Galaxea AI provides an early test case for this new environment. The company confidentially filed for a Hong Kong IPO earlier this year after raising funds at a valuation of roughly $3 billion. However, some investors worry that its financial outlook may not satisfy the increased scrutiny. This does not guarantee the IPO will fail, but it signals that the conversation has moved away from ambitious production targets toward less glamorous questions about cost and customer retention.

Manufacturing Scale Does Not Equal Deployment

China has built formidable manufacturing capabilities, with AgiBot announcing that its 15,000th robot rolled off the production line in June. Yet, producing robots at scale is different from deploying them for productive industrial work. Data from Morgan Stanley suggests that most of the 12,000 humanoids sold in China in 2025 went to research and educational sectors rather than commercial applications.

Unitree’s financials reinforce this distinction. Less than 10% of its humanoid revenue in the first nine months of 2025 came from industrial applications like manufacturing or power grids. This indicates that commercialization remains in its early stages. Investors are increasingly looking for metrics such as utilization rates and autonomous operating hours, rather than just the number of units shipped.

The Shift Toward Industrial Utility

The industry is now being judged on whether robots are performing work that customers will repeatedly pay for. As noted by GN auto tech/robotics, the focus is moving from technical demonstrations to sustainable business models. The key question is no longer whether a robot can move, but whether it can operate efficiently enough to be profitable in a real-world setting.

This transition poses a significant challenge for the sector. While production capacity is a strength, the lack of widespread industrial adoption means that many companies are still primarily research platforms. The coming months will reveal whether humanoid robots can transition from novelty to necessity, or if the bubble will deflate under the weight of financial reality.